LEPTIN LEVEL  IN NON DIABETIC POPULATION WITH AND WITHOUT NON ALCOHOLIC FATTY LIVER (NAFL)

Noor Asyiqah Sofia

doi:10.22146/acta interna.3853

LEPTIN LEVEL IN NON DIABETIC POPULATION WITH AND WITHOUT NON ALCOHOLIC FATTY LIVER (NAFL)

https://doi.org/10.22146/acta%20interna.3853

Noor Asyiqah Sofia^(1*)

(1)
(*) Corresponding Author

Abstract

ABSTRACT

Background. Non alcoholic fatty liver disease (NAFLD) is a prevalent condition associated with obesity and insulin resistance. Leptin is an adipokine which plays role in decreasing food intake and controlling energy utilization. The role of leptin pathogenesis of NAFLD remains unclear. Former studies associated with the role of leptin in NAFL were never conducted in diabetic patients. Therefore we aimed to analyze the difference of leptin level in non diabetic population between subjects with and without non alcoholic fatty liver disease.

Method. This was a non matching case control study in general check up polyclinic Dr.Sardjito Hospital Yogyakarta. The inclusion criteria were aged 30-60 years old, no history of alcohol consumption > 20 gr/day, no diabetes mellitus. The exclusion criteria were viral hepatitis (B and C), rapid weight loss, steroid therapy, and pregnancy. Diagnosis of NAFL was based on bright liver imaging from ultrasonography.

Result. There were 48 subjects consist of 23 subjects with NAFL and 25 subjects without NAFL. Mean of leptin level in NAFL group was higher than non NAFL group and this difference was statistically significant (20.29 + 15.73 ng/ml and 12.27 + 10.1 ng/ml; p=0.040).

Conclusion. The conclusion of this study was leptin level significantly higher in non diabetic population with NAFL compared with non NAFL.

Keywords: leptin, non diabetic, non alcoholic fatty liver

Full Text:

PDF

References

Targher. G.. Bertolini. L.. Poli. F.. Rodella. S.. Scala. L.. Tessari. R.. et al.. . Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients. Diabetes. 2005; 54:3541-3546.

Kim. S.G.. Kim. H.Y.. Seo. J.A.. Lee. K.W.. Oh. J.H.. Kim. N.H.. et al.. . Relationship Between Serum Adiponektin Concentration. Pulse Wave Velocity and Nonalcoholic Fatty Liver Disease. Europ J of Endocrinol 2005; 152: 225-231.

Kim. C.H.. Younossi. Z.M.. 2008. Nonalcoholic Fatty Liver Disease: A Manifestation of the Metabolic Syndrome. Cleveland Clinic Journal of Medicine;75(10):721-728.

Hasan. I.. Perlemakan Hati Non Alkoholik. Dalam: Sudoyo. A.W.. Setiyohadi. B.. Alwi. I.. Simadibrata. M. K.. Setiati. S.. 2006. Buku Ajar Ilmu Penyakit Dalam; Ed4th. Departemen Ilmu Penyakit Dalam FK UI. Jakarta.2006. 1: 464-468.

Ahima. R.S.. Adipose Tissue as An Endocrine Organ. Obesity; Vol.14 : 2006. 242S-249S.

Meier. U.. dan Gressner. A.M,.Endocrine Regulation of Energy Metabolism: Review of Pathobiohemical and Clinical Chemical Aspects of Leptin. Ghrelin. Adiponectin. and Resistin. Clinical Chemistry2004.; 50 (9): 1511-25.

Huang. XD.. Fan. Y.. Zhang. H.. Wang. P.. Yuang. J.P.. Li. MJ.. et al.. Serum Leptin and Soluble Leptin Receptor in Non-alcoholic Fatty Liver Disease. World J Gastroenterol. 2008.;14(18):2888-2893.

Diehl. A.M.. Nonalcoholic Steatosis and Steatohepatitis IV. Nonalcoholic Fatty Liver Disease Abnormalities in Macrophage Function and Cytokines. Am J Physiol Gastrointest Liver Physiol. 2002; 282: 1-5.

Mantzoros. C.S.. The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence. Ann Intern Med.1999; 130:671-80.

Chitturi S.. Farrel G.. Frost L.. Kriketos A.. Lin R.. Liddle C. et al. . Serum Leptin in NASH Correlates With Hepatic Steatosis but Not Fibrosis: A Manifestation of Lipotoxicity? Hepatology 2002. 36:403-409.

Mendez. N.S.. Chavez. N.C.T.. Villa. A.R.. Sanchez. K.L.. Zamora. D.V.. Ramos. M.H.. et al.. Adiponectin as a Protective Factor in Hepatic Steatosis. World J Gastroenterol. 2005. 11(12): 1737-1741.

Uygun. A.. Kadayifci. A.. Yesilova. Z.. Erdil. A.. Yaman. H.. Saka. M.. et al.. Serum Leptin Levels in Patients with Nonalcoholic Steatohepatitis. Am J Gastroenterol.2000; 95(12):3584-9.

Zhang. G.. Nie. L.. Leptin and Estrogen in Pathogenesis of Nonalcoholic Fatty Liver Disease in Male Adults. World Chin J Digestol.2004;12(8):1897-1899.

Chalasani N.. Crabb D.W.. Cummings O.W. Does Leptin Play a Role In The Pathogenesis of Human Nonalcoholic Steatohepatitis? The American Journal of Gastroenterology. 2003.98(12):2771-2776.

Musso G.. Gambino R.. Durazzo M. Adipokines in NASH: Postprandial Lipid Metabolism as a Link Between Adiponectin and Liver Disease. Hepatology. 2005. 42(5):1175-1183.

Tsochatzis E.A.. Papatheodoridis G.V.. Archimandritis A. J.. Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy. Mediators of Inflammation. 2009. doi:10.1155/2009/831670.

Bugianessi. E.. Belentani. S.. Bedogni. G.. Tribelli. C.. Clinical Update on Non-alcoholic Fatty Liver Disease and Steatohepatitis. Annals of Hepatology. 2008; 7(2):157-160.

Adam. J.M.F.. Obesitas dan Diabetes Mellitus Tipe 2 dalam Adam. J.M.F (ed). Obesitas dan Sindroma Metabolik. Bandung. 2006.

Nasri. H.. Serum Leptin Concentration and Left Ventricular Hypertrophy and Function in Maintenance Hemodialysis Patients. Acta Fac Med Naiss 2006. 23(1):3-7.

DOI: https://doi.org/10.22146/acta%20interna.3853